The estimated Net Worth of Stephen Berenson is at least $2.27 million dollars as of 3 May 2024. Mr. Berenson owns over 732 units of Moderna Inc stock worth over $1,765,361 and over the last 6 years he sold MRNA stock worth over $0. In addition, he makes $500,000 as Non-Executive Independent Director at Moderna Inc.
Stephen has made over 3 trades of the Moderna Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 732 units of MRNA stock worth $58,201 on 3 May 2024.
The largest trade he's ever made was exercising 732 units of Moderna Inc stock on 3 May 2024 worth over $58,201. On average, Stephen trades about 124 units every 43 days since 2018. As of 3 May 2024 he still owns at least 22,203 units of Moderna Inc stock.
You can see the complete history of Mr. Berenson stock trades at the bottom of the page.
Stephen Berenson serves as Non-Executive Independent Director of the Company. Mr. Berenson is a Managing Partner at Flagship Pioneering. Prior to that, Mr. Berenson spent 33 years as an investment banker at J.P. Morgan. During his last twelve years at J.P. Morgan, Mr. Berenson was Vice Chairman of Investment Banking and focused on providing high-touch strategic advice and complex transaction execution to leading companies across all industries globally. He was co-founder of J.P. Morgan’s Global Strategic Advisory Council and co-founder of the firm’s Board Initiative. Mr. Berenson also serves as Chairman of the board of directors of Seres Therapeutics, Inc. (Nasdaq: MCRB) and on the board of directors of CiBO Technologies, Inc. Mr. Berenson received an S.B. in mathematics from MIT.
As the Non-Executive Independent Director of Moderna Inc, the total compensation of Stephen Berenson at Moderna Inc is $500,000. There are 13 executives at Moderna Inc getting paid more, with Stephane Bancel having the highest compensation of $8,948,210.
Stephen Berenson is 59, he's been the Non-Executive Independent Director of Moderna Inc since 2017. There are 4 older and 14 younger executives at Moderna Inc. The oldest executive at Moderna Inc is Elizabeth Tallett, 71, who is the Director.
Stephen's mailing address filed with the SEC is C/O SERES THERAPEUTICS, INC., 101 CAMBRIDGE PARK DRIVE, CAMBRIDGE, MA, 02140.
Over the last 6 years, insiders at Moderna Inc have traded over $2,713,086,305 worth of Moderna Inc stock and bought 52,631 units worth $999,989 . The most active insiders traders include Noubar Afeyan, David M. Rubenstein et Stephane Bancel. On average, Moderna Inc executives and independent directors trade stock every 2 days with the average trade being worth of $2,841,687. The most recent stock trade was executed by Shannon Thyme Klinger on 6 September 2024, trading 1,139 units of MRNA stock currently worth $90,562.
moderna is pioneering messenger rna therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. this breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions. moderna has developed a broad intellectual property estate including more than 200 patent applications with more than 10,000 claims ranging from novel nucleotide chemistries to specific drug compositions. the company plans to develop and commercialize its innovative mrna drugs—initially for rare diseases and oncology—while partnering drug candidates in other therapeutics areas in order to rapidly deliver this innovation to patients. based in cambridge, massachusetts, moderna is privately held and was founded in 2010 by flagship venturelabs in association with leading scientists from boston children’s hospital a
Moderna Inc executives and other stock owners filed with the SEC include: